Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
bioAffinity Technologies, Inc. - Warrant
(NQ:
BIAFW
)
0.3547
UNCHANGED
Streaming Delayed Price
Updated: 3:30 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
17
Open
0.3547
Bid (Size)
0.2001 (3)
Ask (Size)
0.4611 (1)
Prev. Close
0.3547
Today's Range
0.3547 - 0.3547
52wk Range
0.0460 - 0.9000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
bioAffinity Technologies News Update
May 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 24, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Performance
YTD
+215.57%
+215.57%
1 Month
-49.40%
-49.40%
3 Month
+294.55%
+294.55%
6 Month
+588.74%
+588.74%
1 Year
+18.23%
+18.23%
More News
Read More
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies In The News
January 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies In the News
January 08, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 30, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
November 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 06, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
October 10, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
September 07, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
July 12, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
June 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
May 01, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
April 25, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 02, 2022
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.